IFN-γ can have direct anti-tumor effects by upregulating MHC class I molecules on tumor cells, enhancing their recognition by other immune cells like cytotoxic T cells (CD8+ T cells) and NK cells. This evidence concerns the gene IFNG and neoplasm.